HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taisho Boosted By Acquisitions As Japanese Business Struggles

Executive Summary

Acquiring France's UPSA helped to lift Taisho's sales in the 12 months ended 31 March 2020, as its domestic Japanese business faltered.

You may also be interested in...



Cooper Divests Stardea To France's EA Pharma

Italian nutraceutical player Stardea has changed hands. Following six years of ownership by Cooper Consumer Health, the business has been acquired by France's EA Pharma which is keen to expand its footprint outside of its home market.

New EU Limits On Pyrrolizidine Alkaloids In Dietary Supplements Take Effect

Following a transitional period of 18 months, maximum levels for pyrrolizidine alkaloids in dietary supplements come into force in the EU from 1 July 2022 for new products placed on the market. Pyrrolizidine alkaloids have been under scrutiny in the EU for over a decade as their consumption has been linked to a number of health issues, including liver damage.

Nestlé Spies APAC Expansion Potential With Deal for New Zealand's Better Health

Nestlé Health Science continues to expand its dietary supplements offering in 2022 penning a deal for New Zealand's The Better Health Company and its GO Healthy brand. The company says the deal will strengthen its presence not just in New Zealand but across the wider APAC region in markets such as Australia and China.

Topics

Latest News
UsernamePublicRestriction

Register

RS150051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel